OnCo
trialsTrialCompleted

Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide

A phase 2 trial of Pamidronate, Thalidomide and Zoledronic acid in Multiple myeloma, run by University of Arkansas, completed.